25th March 2026 – The Unloved Child Podcast: Biometrics & Biostatistics in Drug Development & Clinical Trials

Physiomics’ Head of Biometrics discusses the role of biostatistics, clinical trial strategy and his experience in quantitative decision-making in modern drug development

We are pleased to share this podcast featuring our Head of Biometrics, Jesse Thissen, who was invited to discuss his experience working in biometrics and the growing role of biostatistics in drug development and clinical trials.

In the discussion, Jesse shares insights into how biometrics supports clinical development strategy, informs decision-making throughout drug development and helps biotech and pharma companies improve the probability of clinical and commercial success.

Topics covered include:

• The difference between a standard CRO and a strategic biometrics partner
• The importance of early statistical planning to assess study size, budget requirements, and probability of success throughout development
• How effective clinical trial design can help ensure studies answer the right questions from the outset
• The importance of cross-functional collaboration and communication in successful drug development programmes
• The evolving role of biometrics and biostatistics in supporting data-driven drug development decisions

Watch the full episode here

We would like to thank James Carpenter at JCR Pharma for the invitation and engaging discussion.